You are here

IPOs

Two Biopharmas Nix IPO Plans in Unstable Market

BioSpace

Thu, 10/21/21 - 11:18 pm

IPO floodgates open up after summer lull as five more biotechs file for Nasdaq

Endpoints

Tue, 10/12/21 - 10:59 am

Entrada Therapeutics

Aura Biosciences

Blue Water Vaccines

Pfizer, Bayer-backed Pyxis ups IPO price as biotech's public run continues unabated

Fierce Biotech

Fri, 10/8/21 - 10:39 am

OrbiMed's TKI play makes its Nasdaq debut as Theseus prices IPO

Endpoints

Thu, 10/7/21 - 11:13 am

Theseus Pharmaceuticals

Biotech listings show signs of a slowdown

EP Vantage

Wed, 10/6/21 - 10:38 am

Adagio Therapeutics

Caribou Biosciences

DiCE Therapeutics

This Recent Biologics IPO Could Be Heading Toward a Gain of 60% or More

Motley Fool, clinical trials,

Mon, 10/4/21 - 10:37 am

Rani Therapeutics

The cash won't stop for Exscientia as it makes a $300M+ Nasdaq debut

Endpoints

Sun, 10/3/21 - 08:16 pm

artificial intelligence

Covid has made biotech companies the hot new tech sector as investor demand drives record IPOs

CNBC

Fri, 10/1/21 - 10:42 am

A New Medtech IPO Could Be on the Way

Medical Devices and Diagnostics Industry

Tue, 09/28/21 - 12:03 am

Lucid Diagnostics

Cue Health, Google's COVID-19 test provider, raises $200M in an IPO

Medtech Dive

Mon, 09/27/21 - 10:56 am

Bankrolled by Pfizer and Bayer, Pyxis files for $100M IPO to take cancer drugs into the clinic

Fierce Pharma

Mon, 09/20/21 - 11:17 am

Three more biotechs hit Nasdaq as the sector, now with more than $13B raised, continues barreling toward record

Endpoints

Wed, 09/15/21 - 10:56 am

Pasithea Therapeutics

Tyra Biosciences

DiCE Therapeutics

Five Life Sciences Companies Ramping up the Fall Flood of IPOs

BioSpace

Mon, 09/13/21 - 11:28 pm

Sumitomo Dainippon Pharma

Tyra Biosciences

Procept BioRobotics

IPO filings are back on the biotech menu as an ADHD drug developer submits its Nasdaq paperwork

Endpoints

Fri, 09/10/21 - 11:12 am

After pandemic delay and a South Korean deal, Boston-area biotech raises Series B with sights on IPO

Endpoints

Thu, 08/26/21 - 10:59 am

Tyra Biosciences wants to bank $100M for an IPO

Fierce Biotech

Mon, 08/23/21 - 11:02 am

Tyra Biosciences

Dermata Therapeutics prices ~$18M IPO

Seeking Alpha

Fri, 08/13/21 - 12:05 pm

Dermata Therapeutics

Virtually unknown mRNA upstart rides SPAC to Nasdaq with a $1.5B valuation as RA-backed neuro player prices IPO

Endpoints

Tue, 08/10/21 - 10:38 am

GreenLight Biosciences

Bayer bets $1.5B that Vividion will help it target the 'undruggable' and make 1+1=3

Fierce Biotech

Thu, 08/5/21 - 11:11 am

Icosavax’s $182M IPO haul is key for RSV, but eyes are on its Covid vaccine too

MedCity News

Sun, 08/1/21 - 11:53 pm

Pages